News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
551,642 Results
Type
Article (40420)
Company Profile (73)
Press Release (511149)
Multimedia
Podcasts (44)
Webinars (12)
Section
Business (153517)
Career Advice (2433)
Deals (27987)
Drug Delivery (99)
Drug Development (73113)
Employer Resources (144)
FDA (13948)
Job Trends (12304)
News (273865)
Policy (27184)
Tag
Academia (2554)
Academic (1)
Accelerated approval (5)
Adcomms (26)
Allergies (78)
Alliances (38728)
ALS (90)
Alzheimer's disease (1393)
Antibody-drug conjugate (ADC) (127)
Approvals (13939)
Artificial intelligence (238)
Autoimmune disease (22)
Automation (16)
Bankruptcy (310)
Best Places to Work (10070)
BIOSECURE Act (15)
Biosimilars (90)
Biotechnology (60)
Bladder cancer (80)
Brain cancer (27)
Breast cancer (265)
Cancer (2145)
Cardiovascular disease (186)
Career advice (2045)
Career pathing (32)
CAR-T (144)
Cell therapy (395)
Cervical cancer (16)
Clinical research (59681)
Collaboration (710)
Company closure (1)
Compensation (284)
Complete response letters (22)
COVID-19 (2465)
CRISPR (39)
C-suite (251)
Cystic fibrosis (83)
Data (2124)
Decentralized trials (2)
Denatured (6)
Depression (51)
Diabetes (256)
Diagnostics (5735)
Digital health (14)
Diversity (4)
Diversity, equity & inclusion (38)
Drug discovery (111)
Drug pricing (93)
Drug shortages (23)
Duchenne muscular dystrophy (89)
Earnings (55674)
Editorial (38)
Employer branding (18)
Employer resources (130)
Events (75960)
Executive appointments (718)
FDA (15112)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (6)
Funding (661)
Gene editing (99)
Generative AI (19)
Gene therapy (299)
GLP-1 (691)
Government (4142)
Grass and pollen (5)
Guidances (64)
Healthcare (16169)
Huntington's disease (24)
IgA nephropathy (29)
Immunology and inflammation (127)
Indications (27)
Infectious disease (2607)
Inflammatory bowel disease (129)
Inflation Reduction Act (8)
Influenza (50)
Intellectual property (88)
Interviews (522)
IPO (12630)
IRA (41)
Job creations (2614)
Job search strategy (1674)
Kidney cancer (11)
Labor market (19)
Layoffs (422)
Leadership (23)
Legal (5828)
Liver cancer (73)
Lung cancer (319)
Lymphoma (144)
Machine learning (6)
Management (52)
Manufacturing (255)
MASH (74)
Medical device (11070)
Medtech (11074)
Mergers & acquisitions (15838)
Metabolic disorders (664)
Multiple sclerosis (77)
NASH (23)
Neurodegenerative disease (99)
Neuropsychiatric disorders (31)
Neuroscience (1937)
NextGen: Class of 2025 (5571)
Non-profit (4001)
Now hiring (31)
Obesity (342)
Opinion (210)
Ovarian cancer (72)
Pain (87)
Pancreatic cancer (80)
Parkinson's disease (145)
Partnered (18)
Patents (218)
Patient recruitment (108)
Peanut (41)
People (51172)
Pharmaceutical (22)
Pharmacy benefit managers (10)
Phase I (18370)
Phase II (26243)
Phase III (20020)
Pipeline (1158)
Policy (132)
Postmarket research (2326)
Preclinical (7530)
Press Release (54)
Prostate cancer (99)
Psychedelics (37)
Radiopharmaceuticals (214)
Rare diseases (360)
Real estate (4140)
Recruiting (58)
Regulatory (19216)
Reports (25)
Research institute (2135)
Resumes & cover letters (356)
Rett syndrome (5)
RNA editing (3)
RSV (39)
Schizophrenia (75)
Series A (117)
Series B (75)
Service/supplier (3)
Sickle cell disease (52)
Special edition (10)
Spinal muscular atrophy (145)
Sponsored (28)
Startups (2785)
State (2)
Stomach cancer (14)
Supply chain (58)
Tariffs (31)
The Weekly (37)
Vaccines (637)
Venture capitalists (31)
Weight loss (230)
Women's health (25)
Worklife (17)
Date
Today (20)
Last 7 days (713)
Last 30 days (2160)
Last 365 days (28551)
2025 (9391)
2024 (30814)
2023 (34391)
2022 (44915)
2021 (48151)
2020 (46706)
2019 (40038)
2018 (30339)
2017 (27350)
2016 (25956)
2015 (30364)
2014 (22849)
2013 (18671)
2012 (19936)
2011 (20832)
2010 (18494)
Location
Africa (723)
Alabama (48)
Alaska (4)
Arizona (151)
Arkansas (11)
Asia (34089)
Australia (7063)
California (5080)
Canada (1811)
China (469)
Colorado (226)
Connecticut (216)
Delaware (133)
Europe (75908)
Florida (817)
Georgia (168)
Idaho (49)
Illinois (464)
India (23)
Indiana (281)
Iowa (7)
Japan (152)
Kansas (94)
Kentucky (19)
Louisiana (8)
Maine (49)
Maryland (780)
Massachusetts (3642)
Michigan (194)
Minnesota (300)
Mississippi (1)
Missouri (75)
Montana (21)
Nebraska (22)
Nevada (57)
New Hampshire (63)
New Jersey (1510)
New Mexico (21)
New York (1486)
North Carolina (804)
North Dakota (5)
Northern California (2209)
Ohio (170)
Oklahoma (6)
Oregon (25)
Pennsylvania (1150)
Puerto Rico (12)
Rhode Island (27)
South America (992)
South Carolina (20)
South Dakota (1)
Southern California (1967)
Tennessee (81)
Texas (781)
United States (19313)
Utah (167)
Virginia (132)
Washington D.C. (51)
Washington State (472)
West Virginia (3)
Wisconsin (43)
551,642 Results for "corindus vascular robotics formerly known as corindus".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Hemostemix and FireFly Neuroscience’s Brain Network Analytics (BNA(TM)) Engage to Complete Phase 1 Vascular Dementia Clinical Trial of ACP-01
A growing body of clinical evidence supports the use of Firefly’s FDA-Cleared BNA(TM) platform to study ACP-01 as a treatment for vascular dementia
March 6, 2025
·
10 min read
Genetown
Corindus, A Siemens Healthineers Company, Announces Study Results Demonstrating Safety and Effectiveness of CorPath® GRX Neurovascular System
Corindus , A Siemens Healthineers Company and a leading developer of precision vascular robotics, announced today it presented the results of a first-of-its-kind study demonstrating the safety and effectiveness of robotic-assisted neurovascular aneurysm embolization using the CorPath GRX Neurovascular System.
September 12, 2022
·
4 min read
Press Releases
Averna Therapeutics, formerly known as Exsilio Therapeutics, Appoints Thomas M. Barnes, Ph.D., as Chief Executive Officer
January 27, 2025
·
3 min read
Genetown
Corindus, A Siemens Healthineers Company, to Showcase CorPath® GRX Robotic System at EuroPCR 2022
Corindus announced that it will showcase the CorPath GRX System, the first and only FDA-cleared and CE marked medical device for robotic-assisted coronary interventions, at EuroPCR 2022 through live cases, scientific presentations, and multiple Siemens Healthineers-sponsored symposia.
May 12, 2022
·
4 min read
Press Releases
Spectrum Vascular Welcomes New Executive Leadership
April 14, 2025
·
4 min read
Press Releases
Elixir Medical Announces First Use of LithiX Hertz Contact (HC) Intravascular Lithotripsy System (IVL) in Asia Pacific at Cardiac Vascular Sentral Kuala Lumpur (CVSKL), Malaysia
April 25, 2025
·
2 min read
Breast cancer
AstraZeneca, Daiichi Sankyo’s ADC Wins First Approval Despite Mixed Data
Datroway, formerly known as Dato-DXd, significantly improved median progression-free survival in a Phase III study but failed to do so for overall survival.
January 21, 2025
·
2 min read
·
Tristan Manalac
Press Releases
FluidForm Bio™ Advances Vascularized Tissue Engineering with New FRESH™ 3D Bioprinting Breakthrough
April 15, 2025
·
2 min read
Press Releases
CORRECTING and REPLACING Access Vascular Highlights New Midline Catheter Data at AVA 2024
Data Presented at the AVA Annual Scientific Meeting Shows Significantly Lower Complication and Failure Rates with Access Vascular’s HydroMID® Midline Catheter
October 2, 2024
·
2 min read
Press Releases
Vivasure Medical Receives CE Mark Approval in Europe for PerQseal Elite Vascular Closure System
April 22, 2025
·
2 min read
1 of 55,165
Next
